Erreger virales hemorraghisches Fieber (hier: Ebola-, Krim-Kongo-, Lassa-, Marburgvirus) und sich noch nicht in einem STAKOB Behandlungszentrum befindet (Stand 30.5.2018)
Wenn der Verdacht auf eine reiseassoziierte Infektion mit einem Erreger eines viral-hämorrhagischen Fiebers (VHF) bei einem fi...ebrigen Patienten besteht, sollte trotzdem zunächst immer (auch) an Malaria gedacht werden, die unverzüglich behandelt werden muss.
more
La transmisión de T. cruzi de un donante con la enfermedad de Chagas a un receptor de trasplante es poco frecuente y es resultado de la aplicación de un tratamiento quirúrgido. En este documento se proponen diez pautas para manejar y prevenir la transmisión de la enfermedad de Chagas por traspla...nte de órganos.
more
Because malaria cases are seen relatively rarely in North America, misdiagnosis by clinicians and laboratorians has been a commonly documented problem in published reports. However, malaria may be a common illness in areas where it is transmitted and therefore the diagnosis of malaria should routine...ly be considered for any febrile person who has traveled to an area with known malaria transmission in the past several months preceding symptom onset.
more
Key Malaria Indicators from the 2017 Rwanda Malaria Indicator Survey - The table in this key indicator report provides estimates of key indicators for the country as a whole and for each of the five provinces in Rwanda.
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...acilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it identifies and reviews priority needs, works towards standardization of methodology to assess drug efficacy and reviews alternatives for using current approved drugs (new schemes, doses, combination) and special scenarios (resistance).
more
Accessed on 10.03.2020
Introduction pour lire et comprende les tableaux de l’Enquête sur les Indicateurs du Paludisme au Burkina Faso.
Nigeria Malaria Indicator Survey (NMIS) - Key Indicators 2021
A new mobile learning courses developed by CapacityPlus lead partner IntraHealth International offer specialized guidance on care and prevention for health workers in Ebola-affected areas, delivered through SMS text messages or through interactive voice response on simple mobile phones. The reources... will be available on the IntraHealth International website
more
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...lombia, 437 000 people are infected with T. cruzi, of whom 131 000 suffer from cardiomyopathy. Colombia’s annual costs for treating patients with advanced CD reach US$ 175 016 000. Although timely etiological treatment can significantly delay or prevent development of cardiomyopathy—and costs just US$ 30 per patient—fewer than 1% of people with CD in Colombia and elsewhere receive it.
more
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.